Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03321578
Other study ID # v10.5
Secondary ID
Status Completed
Phase N/A
First received October 23, 2017
Last updated October 23, 2017
Start date January 2016
Est. completion date August 2016

Study information

Verified date October 2017
Source The Leeds Teaching Hospitals NHS Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This service evaulation aims to investigate how common diarrhoea is in hospital patients on medical, surgical and elderly care wards, what it is due to and how it is managed.


Description:

Latest National Health Service (NHS) England guidelines for the assessment of Clostridium difficile infection (CDI) cases recommend that acute hospitals collect data on the prevalence of hospital-onset diarrhoea in their organisations, and how it is managed, including if patients are appropriately tested for CDI.

The aims of this multi-centre service evaluation are therefore to:

- Determine the prevalence of hospital-onset diarrhoea on adult medical, surgical and care of the elderly wards in the NHS

- Investigate how hospital-onset diarrhoea is managed, including whether patients are tested for CDI according to Department of Health (DoH) England standards

- Investigate the aetiology of hospital-onset diarrhoea on adult medical, surgical and care of the elderly wards in the NHS, based on previously described causes

Data will be collected at participating centres on two days, one between 11-15/Jan/2016 and one between 6-10/Jun/2016. Hospitals will be able to choose locally which two days. On those days investigators from the local Microbiology and/or Infection Prevention teams will screen all patients on pre-identified wards, who have been admitted for ≥72 hours, for hospital-onset diarrhoea. For all patients that meet the definition of hospital-onset diarrhoea their medical notes and charts will be reviewed, to ascertain potential causes and how they have been managed.

This service evaluation should help participating hospitals to investigate hospital-onset diarrhoea in their own institutions, as well as generating a dataset that is representative of the problem across the NHS, and therefore of use to other centres.


Recruitment information / eligibility

Status Completed
Enrollment 230
Est. completion date August 2016
Est. primary completion date June 2016
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria:

- Admitted to hospital for =72 hours at the time of data collection for the service evaluation

- Presence of hospital-onset diarrhoea (defined as = 2 episodes of unformed stools (Bristol Stool Chart type 5-7) during the day before the service evaluation, with the onset of the diarrhoea being more than 48 hours after admission to hospital)

Exclusion Criteria:

- Patients admitted to the ward for =72hour at the time of data collection for the service evaluation

- Patients with diarrhoea since admission or in whom it developed within the first 48 hours of admission

- Patients receiving end of life care

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United Kingdom Antrim Area Hospital (Northern Health and Social Care Trust) Antrim
United Kingdom Barnsley Hospital NHS Foundation Trust Barnsley
United Kingdom East Lancashire Hospitals NHS Trust Blackburn
United Kingdom Cambridge University Hospitals NHS Foundation Trust Cambridge
United Kingdom University Hospitals Coventry and Warwickshire + George Eliot Hospital NHS Trust Coventry
United Kingdom Ulster Hospital (South Eastern Health and Social Care Trust) Dundonald
United Kingdom NHS Lothian and NHS Fife Edinburgh
United Kingdom NHS Greater Glasgow and Clyde Glasgow
United Kingdom Harrogate and District NHS Foundation Trust Harrogate
United Kingdom Hull and East Yorkshire Hospitals NHS Trust Hull
United Kingdom University Hospitals of Leicester NHS Trust Leicester
United Kingdom Guy's & St Thomas' NHS Foundation Trust London
United Kingdom The Royal Free London NHS Foundation Trust London
United Kingdom South Tees Hospitals NHS Foundation Trust Middlesborough
United Kingdom Aneurin Bevan University Health Board Newport
United Kingdom Nottingham University Hospitals NHS Trust Nottingham
United Kingdom Oxford University Hospitals NHS Trust Oxford
United Kingdom Papworth Hospital NHS Foundation Trust Papworth
United Kingdom Sheffield Teaching Hospitals NHS Foundation Trust Sheffield
United Kingdom Torbay and South Devon Healthcare NHS Foundation Trust Torbay
United Kingdom Mid Yorkshire NHS Trust Wakefield
United Kingdom Hampshire Hospitals NHS Foundation Trust Winchester
United Kingdom The Royal Wolverhampton NHS Trust Wolverhampton
United Kingdom York Teaching Hospital NHS Foundation Trust York

Sponsors (26)

Lead Sponsor Collaborator
The Leeds Teaching Hospitals NHS Trust Aneurin Bevan University Health Board, Barnsley Hospital NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, East Lancashire Hospitals NHS Trust, George Eliot Hospital NHS Trust, Guy's and St Thomas' NHS Foundation Trust, Hampshire Hospitals NHS Foundation Trust, Harrogate & District NHS Foundation Trust, Hull and East Yorkshire Hospitals NHS Trust, Mid Yorkshire Hospitals NHS Trust, NHS Greater Glasgow and Clyde, NHS Lothian, Northern Health and Social Care Trust, Nottingham University Hospitals NHS Trust, Oxford University Hospitals NHS Trust, Papworth Hospital NHS Foundation Trust, Royal Free Hospital NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust, South Devon Healthcare NHS Foundation Trust, South Eastern Health and Social Care Trust, South Tees Hospitals NHS Foundation Trust, The Royal Wolverhampton Hospitals NHS Trust, University Hospitals Coventry and Warwickshire NHS Trust, University Hospitals, Leicester, York Teaching Hospitals NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Point-prevalence of hospital-onset diarrhoea At enrollment
Secondary • The proportion of patients with hospital-onset diarrhoea who have been assessed for the problem by a member of the clinical team. At enrollment
Secondary • The proportion of patients with hospital-onset diarrhoea that are tested for CDI (both overall and amongst those who do and do not have an alternative explanation for the diarrhoea). Up to 72 hours after enrollment
See also
  Status Clinical Trial Phase
Completed NCT06283784 - Study To Evaluate The Efficacy of a Proprietary Mix of Live Probiotics In The Prophylaxis Of Diarrhea In Adult Patients N/A
Recruiting NCT03851835 - Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis Phase 3
Completed NCT04003181 - The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon N/A
Completed NCT03596827 - The Protective Immune Response to Attenuated Enterotoxigenic Escherichia Coli Infection N/A
Recruiting NCT05372068 - Cement flooRs AnD chiLd hEalth (CRADLE) N/A
Completed NCT03972618 - Evaluation of the Efficacy of Sawyer Point One Filters in Schools and Homes in the Dominican Republic N/A
Completed NCT05207618 - Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant N/A
Not yet recruiting NCT05052489 - Registry and Clinical Observation of Children With Diarrhoeal Disease
Completed NCT02541695 - Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli N/A
Completed NCT02428647 - Lao Zinc Study: Effects of Two Forms of Daily Preventive Zinc Versus Therapeutic Zinc Supplementation N/A
Completed NCT02197780 - Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD N/A
Completed NCT01968408 - Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children Phase 3
Completed NCT01739231 - Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults Phase 1/Phase 2
Terminated NCT01472211 - Water-based Zinc Intervention Trial in Zinc Deficient Children Phase 0
Completed NCT01371656 - Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Phase 3
Terminated NCT01048567 - Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly Phase 2
Completed NCT01438645 - ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy N/A
Not yet recruiting NCT01382199 - Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients Phase 3
Completed NCT00914225 - Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya N/A
Completed NCT00760851 - Yogurt Study in Children 2-4 Years Old Attending Daycare Phase 3